October 27, 2010
Kythera Appoints François Kress To Board Of Directors
September 20, 2010
Kythera Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
September 20, 2010
Kythera Biopharmaceuticals Announces Proof-of-Concept Study Results for ATX-202 In Vitiligo; Plans to Continue Research Efforts In Pigmentation Disorders
August 30, 2010
Kythera and Bayer Dermatology Unit Intendis Enter Licensing and Development Agreement for Adipolytic Agent ATX-101
April 27, 2010
Kythera Biopharmaceuticals Appoints Industry Veteran as Vice President, Global Clinical Operations
January 8, 2010
KYTHERA Biopharmaceuticals To Present At The 28th Annual J.P. Morgan Healthcare Conference